These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6342551)

  • 1. Epidermal nuclear immunoglobulin deposits in some connective tissue diseases: correlation with ENA antibodies.
    Andersen I; Andersen P; Elling P; Graudal H
    Ann Rheum Dis; 1983 Apr; 42(2):163-7. PubMed ID: 6342551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal nuclear immunoglobulin deposition in connective tissue diseases.
    Rodrigues CJ; de Oliveira RM; Taniwaki NN; Bueno C; Marchiori P; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(4):154-7. PubMed ID: 2135825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speckled (particulate) epidermal nuclear IgG deposition in normal skin. Correlation of clinical features and laboratory findings in 46 patients with a subset of connective tissue disease characterized by antibody to extractable nuclear antigen.
    Prystowsky SD; Tuffanelli DL
    Arch Dermatol; 1978 May; 114(5):705-10. PubMed ID: 348115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to extractable nuclear antigen in the rheumatic diseases.
    McCain GA; Bell DA; Chodirker WB; Komar RR
    J Rheumatol; 1978; 5(4):399-406. PubMed ID: 310883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of basophil sensitization by IgE antibodies to nuclear antigens in connective tissue diseases.
    Camussi G; Tetta C; Benveniste J
    Int Arch Allergy Appl Immunol; 1982; 69(4):358-62. PubMed ID: 6754627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of various methods of detecting antibodies against soluble nuclear antigens.
    Zimmermann-Górska I; Potocka-Michajluk U
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):89-94. PubMed ID: 6816187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed connective tissue disease - a subset with sequential clinical and laboratory features.
    Grant KD; Adams LE; Hess EV
    J Rheumatol; 1981; 8(4):587-98. PubMed ID: 6975376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of speckled staining of epidermal nuclei in direct immunofluorescence. 10 cases (author's transl)].
    Morel P; Peltier AP; Allegre P; Civatte J
    Nouv Presse Med; 1978 Jul 1-8; 7(27):2377-80. PubMed ID: 353722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatology and diagnosis in connective tissue disease. Antibodies to extractable ribonucleoprotein in 123 patients reacting with cell nuclei in the immunofluorescence test.
    Jonsson J
    Scand J Rheumatol; 1976; 5(3):177-83. PubMed ID: 790556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vivo epidermal nuclear reactions: a selective process.
    Koelle MS; Kumar V; Beutner EH; Chorzelski TP
    Br J Dermatol; 1991 Jul; 125(1):48-52. PubMed ID: 1873202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The speckled epidermal nuclear immunofluorescence of mixed connective tissue disease seems to develop as an in vitro phenomenon.
    Iwatsuki K; Tagami H; Imaizumi S; Ginoza M; Yamada M
    Br J Dermatol; 1982 Dec; 107(6):653-7. PubMed ID: 6756463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
    Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
    Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune deposits in normal skin of patients with systemic lupus erythematosus: relationship to the serum capacity to solubilize immune complexes.
    Gabrielli A; Corvetta A; Montroni M; Rupoli S; Danieli G
    Clin Immunol Immunopathol; 1985 Sep; 36(3):266-74. PubMed ID: 4017290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of IgG subclass antibodies anti-ENA (extractable nuclear antigens) in systemic rheumatic diseases.
    Sánchez Ibarrola A; Valdivieso R; Wong E; Sánchez Arroyo R
    Allergol Immunopathol (Madr); 1987; 15(4):195-200. PubMed ID: 3500626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between snRNA species contained in nuclear antigens recognized by autoantibodies and the clinical profile in systemic rheumatic diseases.
    Assens C; Graafland H; Liautard JP; Sri-Widada J; Brunel C; Jeanteur P
    Biomed Pharmacother; 1982; 36(3):134-9. PubMed ID: 6185159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speckled antinuclear antibodies in keratinocytes--what does it mean?
    Bukilica MN; Andrejevic SB; Bonaci-Nikolic BM; Nikolic MM
    Clin Exp Rheumatol; 2002; 20(4):499-504. PubMed ID: 12175105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positive immunofluorescence reaction in cell nuclei in the undamaged skin of patients with systemic connective tissue diseases].
    Plesivcnik M; Vizjak A; Rozman B; Pisek K; Kveder T; Lestan B
    Reumatizam; 1988; 35(1-6):7-17. PubMed ID: 3077198
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
    Habets WJ; de Rooij DJ; Salden MH; Verhagen AP; van Eekelen CA; van de Putte LB; van Venrooij WJ
    Clin Exp Immunol; 1983 Oct; 54(1):265-76. PubMed ID: 6352106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
    Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
    Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-nuclear matrix antibodies in mixed connective tissue disease.
    Salden MH; Van Eekelen CA; Habets WJ; Vierwinden G; Van de Putte LB; Van Venrooy WJ
    Eur J Immunol; 1982 Sep; 12(9):783-6. PubMed ID: 6183128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.